Progression of subclinical atherosclerosis in obstructive sleep apnoea (OSA) Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Genetic determinants of cardiovascular disease in patients with obstructive sleep apnea (OSA) Source: International Congress 2015 – Ring of fire: inflammation and metabolism in sleep-disordered breathing Year: 2015
Determinants of subclinical atherosclerosis in patients with obstructive sleep apnoea Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults III: questionnaires, epidemiology and sleep studies Year: 2015
Albuminuria in moderate and severe obstructive sleep apnoea (OSA) patients Source: International Congress 2015 – Inflammation, biomarkers and hypoxia in sleep disordered breathing Year: 2015
Obstructive sleep apnea syndrome (OSA) and hypercoagulability – What is the impact of sole OSA in the absence of comorbities? Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Transition from obstructive sleep apnea (OSA) to obesity hypoventilation syndrome (OHS) Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults I: questionnaires, epidemiology and sleep studies Year: 2015
Circulating T cells and subclinical atherosclerosis in obstructive sleep apnea Source: International Congress 2014 – Inflammation and obesity: implications for OSA Year: 2014
Alteration of inflammatory mediators in patients with obstructive sleep apnea Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Asthma, obesity, metabolic dysfunction and obstructive sleep apnoea Source: International Congress 2019 – State of the art session: Sleep and breathing disorders Year: 2019
Obstructive sleep apnoea and hypothyroidism Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies Year: 2015
Phenotyping comorbidity in obstructive sleep apnea syndrome Source: International Congress 2015 – Measuring sleep-disordered breathing in children and adults II: questionnaires, epidemiology and sleep studies Year: 2015
Evaluation of lipid profile in patients with obstructive sleep apnea syndrome Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II Year: 2015
8-isoprostanes and resistin as markers of vascular damage in non-hypersomnolent obstructive sleep apnea patients Source: International Congress 2016 – Effects of hypoxia and sleep apnoea on the lung, heart, and vessels Year: 2016
Serum YKL-40 level is associated with apnea hypopnea index in patients with obstructive sleep apnea syndrome Source: International Congress 2014 – Of mice and men: physiology and biology of sleep disordered breathing Year: 2014
Predictors of nocturnal hypertension in obstructive sleep apnea patients with metabolic syndrome Source: Annual Congress 2013 –A metabolic medley: sleep disordered breathing Year: 2013
Vasopressin in patients with obstructive sleep apnoea syndrome – An interventional, case-control study Source: International Congress 2014 – The story continues: impact of OSA on cardiometabolic parameters Year: 2014
Metabolic changes and inflammation in obstructive sleep apnea Source: International Congress 2014 – Sleep disordered breathing 3 Year: 2014
Resistant hypertension and obstructive sleep apnea Source: Annual Congress 2013 –Sleep disordered breathing in special situations I Year: 2013
Association between smoking and concomitant diseases in obstructive sleep apnoea (OSA) Source: International Congress 2015 – To treat or not to treat? Sleep-disordered breathing II Year: 2015
Obstructive sleep apnoea and increased inflammatory activity in non-obese patients with coronary artery disease in the RICCADSA trial Source: Annual Congress 2013 –Burn after reading: inflammation in sleep disordered breathing Year: 2013